FARMAONIL SL
Company details
- Active NIF/CIF: B54076161
-
Telephone: +34 965564059
-
Date of last BORME entry: 24/11/2010
-
Sector: Human Health and Social Work Activities
-
Address: Avenida de la Constitución, 17, 03430 Onil, Alicante, España See in map
-
Website: Not available
-
Featured products:
More information on FARMAONIL SL
-
24/11/2010 | BORME act no.: 1075048 | Register: ALICANTEDepósito de cuentas anuales (Octubre de 2010) -
07/01/2010 | BORME act no.: 9386 | Register: ALICANTEDepósito de cuentas anuales (Diciembre de 2009)
-
12/09/2008 | BORME act no.: 505531 | Register: ALICANTEDepósito de cuentas anuales (Agosto de 2008)
-
28/09/2007 | BORME act no.: 670382 | Register: ALICANTEDepósito de cuentas anuales (Septiembre de 2007)
-
14/03/2006 | BORME act no.: 134934 | Register: ALICANTEConstitución
-
14/03/2006 | BORME act no.: 134934 | Register: ALICANTEDeclaración de unipersonalidad
-
14/03/2006 | BORME act no.: 134934 | Register: ALICANTENombramientos
Other information
The CIF of FARMAONIL SL is B54076161 and its business status is active. Its economic activity belongs to the CNAE 8610 - Hospital activities. Its SIC is 5999 - Detallistas diversos.
FARMAONIL SL has Between 10 and 49 employees employees and an annual turnover of less than 2 million euros. The company is registered in the Mercantile Registry of Alicante. It has a total of 1 registration charges. Its last announcement in Borme was published on 24/11/2010 and the latest ordinary annual accounts are from the year 2023.
You can review the contact information of FARMAONIL SL such as the phone number, address, or website in the Company Data module.
For more information about FARMAONIL SL, you can consult any of our available financial reports, the Annual Accounts of the company, or even check its payment incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about the company name comes from official sources and is updated daily.
Do you want to know more about FARMAONIL SL??
Find out more about this company by consulting these reports:
